you are viewing a single comment's thread.
If we get a partnership for 011 it will likely be big, say 400 million or so.
It will be interesting to see which drug out of the pipeline they try to get the partnership for. And whether they keep the US rights to that particular drug. I know they'd like to keep 100% of CDX-110 and CDX-011 if feasible.